by Maria Kassam | Last updated Oct 26, 2022 | Medication Updates
On October 7th, 2022 the U.S. Food and Drug Administration (FDA) announced its approval of the Boostrix vaccine, commonly known as Tdap (combination of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis) for immunization administration during the third...
by Maria Kassam | Last updated Oct 24, 2022 | Medication Updates, Pharmacy Management, Pharmacy News
Innovation drives progress. When it comes to innovation in the development of new drugs and therapeutic biological products in the pharmaceutical industry, the United States Food and Drug Administration’s (FDA’s) Center for Drug Evaluation and Research (CDER) is a key...
by Maria Kassam | Last updated Oct 12, 2022 | Pharmacy Management, Pharmacy Marketing
It has been estimated that more than 78 million visits to the physician office over a 10 year period are for acute pharyngitis, and among those 15% to 30% of cases originated from Group A Streptococcus (GAS) and 2% from Influenza. In order to reduce the number of...
by Maria Kassam | Last updated Oct 5, 2022 | Pharmacy Management, Pharmacy Marketing
TikTok is a video-sharing platform that has gained major use over the last few years. Because of its popularity, it has become one of the top places to market a business. From short videos making audiences laugh to informative videos solving a problem for consumers,...
by Maria Kassam | Last updated Oct 26, 2022 | COVID-19, Health Trends, Medication Updates, Pharmacy News
On July 6th, 2022 the FDA revised the Emergency Use Authorization (EUA) for Paxlovid. With this update, licensed pharmacists were granted the ability to prescribe Paxlovid to eligible patients, with certain limitations existing to ensure the safety and correct use of...
